News Search Results
May 29, 2025, 07:00 ET Bio-Techne to Present at Investor Conferences
https://investors.bio-techne.com/ir-calendar. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
May 15, 2025, 15:19 ET Single-Cell Genomics and Proteomics: Leading the Future of Biomedical Research
10X GENOMICSAGILENT TECHNOLOGIES INC.BDBIO-RAD LABORATORIES INC.BIO-TECHNEBRUKERF. HOFFMANN-LA ROCHE LTD.ILLUMINA INC.MERCK KGAAPROMEGA CORP.QIAGENSARTORIUS
More news about: BCC Research LLC
May 14, 2025, 07:00 ET ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
May 13, 2025, 15:05 ET Liquid Biopsy Market Boom: Tools, Services, and Diagnostics Unveiled
holds the largest share of the market. Market leaders include: Bio-Rad Laboratories Inc. Bio-TechneDxcover Ltd.Exact Sciences Corp.F. Hoffmann-La Roche Ltd.FreenomeGuardant HealthIllumina Inc.Myriad
More news about: BCC Research LLC
May 12, 2025, 07:00 ET Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
use in diagnostic procedures. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
May 08, 2025, 09:30 ET Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
www.kytopen.com Bio-TechneDavid Clair, Vice President, Investor Relations & Corporate [email protected] 612-656-4416 About Bio-Techne Bio-Techne Corporation
More news about: Kytopen
May 08, 2025, 07:00 ET Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
https://investors.bio-techne.com/ir-calendar. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
May 07, 2025, 10:30 ET Single Cell Analysis Market worth US$7.56 billion by 2030 with 14.7% CAGR | MarketsandMarkets™
Cytek Biosciences (US), Takara Bio Inc. (Japan), bioMérieux (France), Revvity (US), Bio-Techne (US), PacBio (US), Bruker (US), Promega Corporation (US), Oxford Nanopore Technologies Plc (UK), The Menarini Group (Italy),
More news about: MarketsandMarkets
May 07, 2025, 06:30 ET BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
dollar amount or number of shares of common stock. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological
More news about: Bio-Techne Corporation
May 07, 2025, 06:30 ET BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
release. "Despite a dynamic macroenvironment, the Bio-Techne team once again executed at a high level and delivered strong third quarter results," said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. "Our pharma end market continued to improve, especially
More news about: Bio-Techne Corporation
May 06, 2025, 07:00 ET ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.
G-Rex® device at a time. About Bio-Techne Corporation Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
May 01, 2025, 15:02 ET In Vitro Diagnostics: Technologies Transforming Global Healthcare Markets
include: AbbottBecton, Dickinson and Co.BiomerieuxBio-Rad Laboratories Inc.Bio-TechneBrukerDanaher Corp.EKF Diagnostics Holdings PlcF. Hoffmann-La Roche Ltd.Hologic Inc.JSR Corp.Quidelortho
More news about: BCC Research LLC
Apr 29, 2025, 07:00 ET ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Apr 24, 2025, 07:00 ET Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
Bio-Techne's scientific team. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Apr 23, 2025, 07:00 ET Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
https://www.bio-techne.com/about/events/aacr. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations
More news about: Bio-Techne Corporation
Apr 15, 2025, 07:00 ET Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results
Saturday, June 7, 2025. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Apr 07, 2025, 10:30 ET US Single-Cell Analysis Market worth US$2,695.3 million by 2029 with 14.3% CAGR | MarketsandMarkets™
(US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), Standard BioTools (US), Corning Incorporated (US), Cytek Biosciences (US), Revvity (US), Bio-Techne (US), PacBio (US), Bruker (US), Promega Corporation (US), Fluent BioSciences (US), RareCyte, Inc. (US), Cell Microsystems (US), and NanoCellect Biomedical
More news about: MarketsandMarkets
Apr 07, 2025, 08:30 ET ALZpath Named 2025 BRONZE Edison Award Winner for its Proprietary pTau217 Antibody, a Key Biomarker Driving Blood-Based Alzheimer's Disease Diagnostics
licensing agreements with leading global diagnostic and research organizations. These include Roche, Beckman Coulter, Bio-Techne, Alamar Biosciences, and Quanterix. Additionally, ALZpath partners with world-class laboratories, such as Neurocode, to further expand its reach and
More news about: ALZpath, Inc.
Apr 02, 2025, 07:00 ET Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
In Diagnostic Procedures. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Apr 01, 2025, 07:00 ET Data Showcasing ALZpath's Proprietary pTau217 Antibody at AD/PD™ 2025 Demonstrates High Rate of Reliability and Scalability for Alzheimer's Disease Research and Diagnosis
Related Neurological Disorders (AD/PD™). The data is based on recent studies conducted by industry leaders, including Beckman Coulter Diagnostics, Bio-Techne, and Neurocode, and will be presented in seven symposia, seven oral presentations, and two poster presentations. Alzheimer's disease and related
More news about: ALZpath, Inc.
Mar 26, 2025, 07:00 ET Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany
from multiple European markets. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Mar 25, 2025, 09:00 ET ALZpath Adds Biotech Veteran to Board of Directors and Names Prominent Global Researcher as Distinguished Scientific Advisor
licensing agreements with leading global diagnostic and research organizations. These include Roche, Beckman Coulter, Bio-Techne, Alamar Biosciences, and Quanterix. Additionally, ALZpath partners with world-class laboratories, such as Neurocode, to further expand its reach and
More news about: ALZpath, Inc.
Mar 24, 2025, 07:00 ET Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
in diagnostic procedures. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Mar 18, 2025, 07:00 ET ALZpath Named to Fast Company's Annual List of the World's Most Innovative Companies of 2025
being developed for clinical use by Roche, Beckman Coulter, as well as other leading tests used in research from Bio-Techne, Alamar Biosciences, and Quanterix. Notably, Roche and Beckman Coulter's pTau217 assays have received breakthrough
More news about: ALZpath, Inc.
Mar 12, 2025, 14:15 ET Global Markets for 3D Cultures and Organoids: Trends Analysis with Forecast
2029, at a CAGR of 12.7% during the forecast period. Market leaders include: • 3D Biotek LLC • Bio-Techne • Cellink • Charles River Laboratories • Cherry Biotech • Corning Inc. •
More news about: BCC Research LLC